Providing a New Approach to Delivering Chemotherapy

What is the AVAS®?

The job of the AVAS® is to be implanted in a patient and provide repeatable and easy access to the patient arteries. This allows clinicians to isolate a cancerous organ from the rest of the body. Once in isolation, the clinician can then treat that organ with high concentrations of anti-cancer agents such as chemotherapy. Currently, clinicians are treating patients who have colon cancer that has spread to the liver. The AVAS® is approved for use in Europe and Australia.

Amanda’s Story

In 2014 Amanda Thorne was diagnosed with stage IV bowel cancer which meant she had multiple tumour metastases in her liver. After undergoing 9 rounds of intravenous oxaliplatin chemotherapy the side effects on her body were so severe she was unable to continue treatment. The AVAS® and treatment method enabled her to continue chemotherapy treatment without the side effects. Amanda is now 5 years post treatment with the AVAS®. Hear her story.